MAPT and breast cancer: We also found that the expression of KDM7A was upregulated in chemoresistant cells (MCF-7/Adr and MCF-7/Tax), while MAPT and PP14571 were downregulated compared with the chemosensitive breast cancer control cell group (MCF-7/Con).